Japan Medical & Health Tourism Center (JMHC) is a medical coordinator established by the JTB Group, Japan's largest travel agency.

Program Details

Information about medical programs provided by each healthcare institution, including treatment details, schedules, etc.,

  • Kanto / Tokyo
  • medical treatment
  • regenerative medicine
  • diabetes

Diabetes Stem Cell Therapy + Cancer Gene Prevention Package

This is a package that combines diabetes treatment with stem cells and exosomes, along with cancer prevention through gene protein therapy. Depending on the patient's diabetes condition, oral medication may also be administered.

First Day (Week 0): Fat tissue is harvested from the abdomen and sent to the culture center. Intravenous administration of 2V exosomes and 8 units of gene protein.
Second Session (4 weeks later): Intravenous administration of 100 million stem cells and 2V exosomes.
Third Session (8 weeks later): Intravenous administration of 8 units of gene protein and 2V exosomes.
Fourth Session (16 weeks later): Intravenous administration of 8 units of gene protein and 2V exosomes.
Fifth Session (24 weeks later): Intravenous administration of 100 million stem cells and 2V exosomes.
Depending on the patient's diabetes condition, oral medication may also be prescribed. Urgent blood tests, including blood glucose levels, HbA1c, triglycerides, uric acid levels, and kidney function, are conducted at each visit. There have been several reports of diabetes improvement with stem cells or exosomes, and the clinic director has extensive experience in this treatment. Additionally, there is evidence of cancer prevention through gene protein administration.

Providing Medical Institution

GRAND ETERNITY Ginza Clinic

〒104-0061
10th Floor, Kirarito Ginza, 1-8-19, Ginza, Chuo-Ku, Tokyo
Eligibility Criteria/Exclusions for Treatment
Patients with diabetes or those suspected of having diabetes who wish to prevent cancer.